Heparin-induced thrombocytopenia.
Explore this paper's citation graph
Summary
Its frequency, the various techniques used to diagnose the condition, its pathophysiology and approaches that can be used to manage patients with heparin-induced thrombocytopenia are summarized.
- Type
- article
- Published
- 1986-01-01
- Cited by
- 26
- References
- 0
- Access
- Open access
- OpenAlex
- https://openalex.org/W2000250009
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:3271410
Keywords
Heparin, Heparin-induced thrombocytopenia, Platelet factor 4, Platelet, Medicine
References
Cited by
- Efficacy and safety of enoxaparin during hemodialysis: results from the HENOX study.
- [A case of heparin induced thrombocytopenia treated with lepirudin infusion: case report].
- RAZVOJ HEPARINOM INDUCIRANE TROMBOCITOPENIJE 24 GODINE NAKON POČETKA KRONIČNE HEMODIJALIZE
- Heparin-induced thrombosis with a normal platelet count.
- Improved laboratory confirmation of heparin-induced thrombocytopenia type II. Time course of antibodies and combination of antigen and biologic assays.
- Simultaneous Use of Argatroban and Heparin during Cardiopulmonary Bypass
- The First Report of Successful Carotid Stent Implant Using Argatroban Anticoagulation in a Patient with Heparin-Induced Thrombocytopenia and Thrombosis Syndrome
- Laboratory diagnosis of heparin-induced thrombocytopenia type II after clearance of platelet factor 4/heparin complex.
- Low molecular weight heparins: a valuable tool in the treatment of acute coronary syndromes.
- Thrombocytopenia in the Intensive Care Unit Setting
- Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation.
- Argatroban Dosing in Patients with Heparin-Induced Thrombocytopenia
- Clinical Safety and Anticoagulation Efficacy of Low-Molecular-Weight Heparins in Chronic Hemodialysis Patients: A Single Medical Center Experience
- Trouble de l'hémostase aux urgences
- Laboratory evaluation of the bleeding patient.
- Heparin binding to resting and activated platelets.
- A new Low Molecular Weight Heparinoid Org 10172 as Anticoagulant in Hemodialysis
- Effects of Heparin on the Vessel Wall and Blood Cellular Elements
- Heparin‐induced thrombocytopenia‐associated thrombosis: from arterial to venous to venous limb gangrene
- Fractionation of sulfated galactan from the red alga Botryocladia occidentalis separates its anticoagulant and anti-SARS-CoV-2 properties
Related papers
- A Platelet Factor 4‐Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin‐Induced Thrombocytopenia Antibodies
- Delayed-onset heparin-induced thrombocytopenia.
- [Fondaparinux treatment in heparin induced thrombocytopenia:a case report].
- Current management of heparin-induced thrombocytopenia
- The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-induced Thrombocytopenia
- Heparin-induced thrombocytopenia occurring after discontinuation of heparin.
- Heparin-induced thrombocytopenia in a child.
- (75) - Preoperative Screening for Anti-Platelet Factor 4/Heparin Antibodies Does Not Accurately Predict Heparin-Induced Thrombocytopenia Post VAD
- Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis